Neuroblastoma GD2 Expression and Computational Analysis of Aptamer-Based Bioaffinity Targeting.
minimal residual disease
neuroblastoma
oncology
tumor biomarker
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
23 Aug 2021
23 Aug 2021
Historique:
received:
21
07
2021
revised:
10
08
2021
accepted:
11
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
16
9
2021
Statut:
epublish
Résumé
Neuroblastoma (NB) is a neuroectodermal embryonic cancer that originates from primordial neural crest cells, and amongst pediatric cancers with high mortality rates. NB is categorized into high-, intermediate-, and low-risk cases. A significant proportion of high-risk patients who achieve remission have a minimal residual disease (MRD) that causes relapse. Whilst there exists a myriad of advanced treatment options for NB, it is still characterized by a high relapse rate, resulting in a reduced chance of survival. Disialoganglioside (GD2) is a lipo-ganglioside containing a fatty acid derivative of sphingosine that is coupled to a monosaccharide and a sialic acid. Amongst pediatric solid tumors, NB tumor cells are known to express GD2; hence, it represents a unique antigen for subclinical NB MRD detection and analysis with implications in determining a response for treatment. This article discusses NB MRD expression and analytical assays for GD2 detection and quantification as well as computational approaches for GD2 characterization based on high-throughput image processing and genomic data analysis.
Identifiants
pubmed: 34445807
pii: ijms22169101
doi: 10.3390/ijms22169101
pmc: PMC8396649
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Aptamers, Nucleotide
0
Gangliosides
0
ganglioside, GD2
65988-71-8
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ruth S. Holmberg Grant for Faculty Excellence, University of Tennessee at Chattanooga
ID : UTC 2020/2021
Références
Biosens Bioelectron. 2007 May 15;22(11):2456-63
pubmed: 17055241
APMIS. 2019 May;127(5):288-302
pubmed: 30803032
J Clin Oncol. 2009 Mar 1;27(7):1007-13
pubmed: 19171716
N Engl J Med. 2010 Sep 30;363(14):1324-34
pubmed: 20879881
PLoS One. 2013 Nov 13;8(11):e81049
pubmed: 24236209
Cold Spring Harb Perspect Med. 2013 Oct 01;3(10):a014415
pubmed: 24086065
Sci Rep. 2016 Dec 15;6:39245
pubmed: 27976736
Genomics Inform. 2019 Sep;17(3):e30
pubmed: 31610626
J Pathol. 1997 Apr;181(4):394-400
pubmed: 9196436
Radiol Phys Technol. 2017 Sep;10(3):257-273
pubmed: 28689314
Int J Cancer. 1987 Jan 15;39(1):73-6
pubmed: 3539825
Sci Rep. 2020 Jun 25;10(1):10333
pubmed: 32587295
Front Chem. 2016 May 10;4:14
pubmed: 27242994
Nat Commun. 2020 Aug 3;11(1):3877
pubmed: 32747659
J Nucl Med. 2015 Apr;56(4):616-21
pubmed: 25698784
J Clin Oncol. 2009 Jan 10;27(2):289-97
pubmed: 19047291
Cell. 1983 Dec;35(2 Pt 1):359-67
pubmed: 6197179
Crit Rev Oncol Hematol. 2019 Jun;138:38-43
pubmed: 31092383
N Engl J Med. 1991 Jan 24;324(4):219-26
pubmed: 1985243
Drugs Future. 2010;35(8):665
pubmed: 21037966
Curr Top Med Chem. 2015;15(12):1138-52
pubmed: 25866268
Anticancer Res. 2006 May-Jun;26(3A):2075-80
pubmed: 16827147
Cancers (Basel). 2018 Apr 10;10(4):
pubmed: 29642598
Adv Pediatr. 2011;58(1):297-311
pubmed: 21736987
Arch Pathol Lab Med. 2019 Feb;143(2):222-234
pubmed: 30307746
Semin Cancer Biol. 2011 Oct;21(4):238-44
pubmed: 21839839
BMC Bioinformatics. 2015 Dec 01;16:399
pubmed: 26627175
Pediatr Transplant. 2004 Jun;8 Suppl 5:56-66
pubmed: 15125707
J Pediatr Surg. 2014 Feb;49(2):233-40
pubmed: 24528957
Mol Biotechnol. 2021 Mar;63(3):167-183
pubmed: 33423212
J Biomed Mater Res A. 2014 Jan;102(1):49-59
pubmed: 23568770
Curr Med Chem. 2011;18(27):4195-205
pubmed: 21838686
Am J Pathol. 2001 Aug;159(2):493-500
pubmed: 11485908
Cancer Res. 1993 Nov 15;53(22):5395-400
pubmed: 8221677
Exp Mol Pathol. 2019 Aug;109:25-35
pubmed: 31075227
J Oleo Sci. 2011;60(10):537-44
pubmed: 21937853
Clin Cancer Res. 2009 Sep 1;15(17):5323-37
pubmed: 19723653
Front Oncol. 2019 Jun 04;9:455
pubmed: 31214500
Clin Cancer Res. 2020 Jan 1;26(1):122-134
pubmed: 31767563
Biochim Biophys Acta. 2002 Dec 19;1573(3):356-62
pubmed: 12417418
J Immunol Res. 2018 Jul 11;2018:7394268
pubmed: 30116755
J Immunother Emphasis Tumor Immunol. 1996 May;19(3):206-17
pubmed: 8811495
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):3900-5
pubmed: 21368158
Pediatr Clin North Am. 1997 Aug;44(4):919-37
pubmed: 9286292
Chem Asian J. 2010 Oct 4;5(10):2209-13
pubmed: 20806314
Leuk Suppl. 2012 Aug;1(Suppl 2):S3-4
pubmed: 27175241
Sci Rep. 2015 Oct 28;5:15675
pubmed: 26507179
Proc SPIE Int Soc Opt Eng. 2012 Feb 16;8319:
pubmed: 22844574
Am J Pathol. 2003 Aug;163(2):393-9
pubmed: 12875961
Front Oncol. 2020 Jul 07;10:1000
pubmed: 32733795
Nat Rev Cancer. 2013 Jun;13(6):397-411
pubmed: 23702928
Curr Probl Cancer. 2009 Nov-Dec;33(6):333-60
pubmed: 20172369
Med Pediatr Oncol. 2001 Jan;36(1):210-2
pubmed: 11464887
BMC Med Genomics. 2020 Nov 10;13(1):171
pubmed: 33172452
Expert Rev Anticancer Ther. 2017 Oct;17(10):889-904
pubmed: 28780888
Sci Rep. 2020 Jan 27;10(1):1199
pubmed: 31988291
Med Image Anal. 2021 Jan;67:101813
pubmed: 33049577
Pediatr Blood Cancer. 2011 Apr;56(4):578-83
pubmed: 21298742
Expert Opin Ther Targets. 2015 Mar;19(3):349-62
pubmed: 25604432
Biotechnol J. 2020 Mar;15(3):e1900368
pubmed: 31840436
N Engl J Med. 2005 Nov 24;353(21):2243-53
pubmed: 16306521
Mol Genet Metab. 2018 Aug;124(4):230-237
pubmed: 29983310
Sci Rep. 2019 Oct 10;9(1):14501
pubmed: 31601836
Lancet. 1984 Jan 14;1(8368):70-3
pubmed: 6140424
Lancet. 2007 Jun 23;369(9579):2106-20
pubmed: 17586306
Biomed Res Int. 2015;2015:419318
pubmed: 26199940
Nucl Med Biol. 2014 Feb;41(2):179-85
pubmed: 24373858
Pediatr Hematol Oncol. 1989;6(2):73-83
pubmed: 2702075
J Clin Oncol. 2000 Dec 15;18(24):4067-76
pubmed: 11118468
Quant Imaging Med Surg. 2015 Jun;5(3):433-47
pubmed: 26029646
ACS Chem Neurosci. 2017 Oct 18;8(10):2118-2123
pubmed: 28800395
J Clin Oncol. 1986 Mar;4(3):363-9
pubmed: 3081691
Int J Nanomedicine. 2017 Jul 26;12:5313-5330
pubmed: 28794625
ACS Nano. 2010 Jul 27;4(7):3689-96
pubmed: 20550178
Front Oncol. 2019 Aug 07;9:726
pubmed: 31448230
BMC Med Genomics. 2019 Dec 20;12(Suppl 8):178
pubmed: 31856829
Cytometry A. 2013 May;83(5):495-507
pubmed: 23568787
Int J Nanomedicine. 2021 May 10;16:3217-3240
pubmed: 34007175
IEEE Trans Pattern Anal Mach Intell. 2018 Apr;40(4):834-848
pubmed: 28463186
Biomolecules. 2019 Jul 27;9(8):
pubmed: 31357634
J Histochem Cytochem. 2005 Dec;53(12):1433-40
pubmed: 15956022
Int J Mol Sci. 2017 Nov 30;18(12):
pubmed: 29189740
NPJ Genom Med. 2020 Mar 10;5:11
pubmed: 32194984
Anal Chim Acta. 2016 Jan 21;904:92-7
pubmed: 26724767
N Engl J Med. 2010 Jun 10;362(23):2202-11
pubmed: 20558371
Eur J Cancer. 1995;31A(4):572-5
pubmed: 7576971
Cytometry A. 2015 Sep;87(9):806-16
pubmed: 26189784
Nanoscale Res Lett. 2018 Sep 18;13(1):288
pubmed: 30229394
Neoplasia. 2003 Jan-Feb;5(1):53-62
pubmed: 12659670